A murine MHC-Ib molecule, H2-Q9, drives peptide-centric T-cell receptor recognition of a viral antigen
- 1Infection and Immunity Program & Department of Biochemistry and Molecular Biology, Monash Biomedicine Discovery Institute, Monash University, Clayton, Victoria, Australia
- 2Department of Cell and Biological Systems, Penn State College of Medicine, Hershey, Pennsylvania, USA
- 3Department of Microbiology and Immunology, University of Melbourne, Parkville, Victoria, Australia
Abstract
Highly polymorphic classical major histocompatibility complex class I (MHC-Ia) molecules present peptides to T-cell receptors (TCRs) expressed on CD8+ T-cells. In contrast, nonclassical MHC-Ib molecules are less polymorphic, and the structural principles governing their recognition by TCRs remain poorly understood. H2-Q9, a murine Qa-2 family MHC-Ib molecule presents the mouse polyomavirus-derived VP2.139 peptide (HALNVVHDW) to CD8+ T-cells, yet the molecular basis of TCR recognition of H2-Q9/peptide complexes remains unclear. Here, we characterized the interactions of two VP2.139-specific TCRs, C3K and AH1, with the VP2.139 peptide presented by H2-Q9, which showed similar moderate binding affinities. We then determined the structure of the TCR C3K bound to the VP2.139 peptide presented by H2-Q9. TCR C3K adopted a diagonal docking orientation and was tilted toward the N-terminal end of the peptide. The CDR3 loops formed extensive contacts with peptide positions P1–P8, whereas alanine-scanning mutagenesis at positions P1–P7 impaired TCR recognition. Structural comparison of H2-Q9 with classical murine MHC-Ia molecules identified substitutions in the α3-domain that alter the CD8-binding interface and may explain the previously observed absence of CD8 binding to H2-Q9. Together, these findings provide insight into antigen recognition by a monomorphic MHC-Ib molecule.
Related
- UpTCR: a unified progressive knowledge transfer foundation model for robust T-cell receptor-antigen binding recognition
- Sample preparation for direct nanopore based protein identification via tryptic peptide recognition
- Anti-HIV-1 B cell antigen receptor structure and signaling
- Catching enhanced flexibility in antibody-antigen recognition: critical evaluation of physics-based and AI-driven methods.
- SMARTFlexDB: a paired apo–holo RNA structure database and analysis platform for RNA conformational flexibility and small-molecule recognition
BibTeX
@article{tennant2026murine,
title = {{A murine MHC-Ib molecule, H2-Q9, drives peptide-centric T-cell receptor recognition of a viral antigen}},
author = {Luke Tennant and Chacko Jobichen and Mai T. Tran and Carine Farenc and Stephanie Gras and Aron E. Lukacher and Lucy C. Sullivan and Andrew G. Brooks and Jamie Rossjohn},
journal = {The Journal of Biological Chemistry},
year = {2026},
month = sep,
doi = {10.1016/j.jbc.2026.113574},
url = {https://doi.org/10.1016/j.jbc.2026.113574},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - A murine MHC-Ib molecule, H2-Q9, drives peptide-centric T-cell receptor recognition of a viral antigen
AU - Luke Tennant
AU - Chacko Jobichen
AU - Mai T. Tran
AU - Carine Farenc
AU - Stephanie Gras
AU - Aron E. Lukacher
AU - Lucy C. Sullivan
AU - Andrew G. Brooks
AU - Jamie Rossjohn
PY - 2026
DA - 2026/09/17
JO - The Journal of Biological Chemistry
DO - 10.1016/j.jbc.2026.113574
UR - https://doi.org/10.1016/j.jbc.2026.113574
AB - Highly polymorphic classical major histocompatibility complex class I (MHC-Ia) molecules present peptides to T-cell receptors (TCRs) expressed on CD8+ T-cells. In contrast, nonclassical MHC-Ib molecules are less polymorphic, and the structural principles governing their recognition by TCRs remain poorly understood. H2-Q9, a murine Qa-2 family MHC-Ib molecule presents the mouse polyomavirus-derived VP2.139 peptide (HALNVVHDW) to CD8+ T-cells, yet the molecular basis of TCR recognition of H2-Q9/peptide complexes remains unclear. Here, we characterized the interactions of two VP2.139-specific TCRs, C3K and AH1, with the VP2.139 peptide presented by H2-Q9, which showed similar moderate binding affinities. We then determined the structure of the TCR C3K bound to the VP2.139 peptide presented by H2-Q9. TCR C3K adopted a diagonal docking orientation and was tilted toward the N-terminal end of the peptide. The CDR3 loops formed extensive contacts with peptide positions P1–P8, whereas alanine-scanning mutagenesis at positions P1–P7 impaired TCR recognition. Structural comparison of H2-Q9 with classical murine MHC-Ia molecules identified substitutions in the α3-domain that alter the CD8-binding interface and may explain the previously observed absence of CD8 binding to H2-Q9. Together, these findings provide insight into antigen recognition by a monomorphic MHC-Ib molecule.
SN - 0021-9258
SN - 1083-351X
ER -